Valuation
- Market cap
- 20,833,000
- Revenue TTM
- $3,020,000
- Net income TTM
- $-570,000
- PE ratio
- 0.00
- Forward PE
- —
- Profit margin
- -18.87%
- Debt to equity
- 0.00
Trading
- Volume
- 15,700
- Avg volume
- 26,740
- Day's range
- $1.76 – $1.87
- Shares out
- 11,574,000
- Stochastic %K
- 19%
- Beta
- 0.65
- Analysts
- Strong Buy
- Price target
- $5.00
Company profile
TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States and internationally. Its products portfolio includes IMVEXXY for the treatment of moderate-to-severe dyspareunia, a symptom of vulvar and vaginal atrophy due to menopause; BIJUVA to treat moderate-to-severe vasomotor symptoms due to menopause in women with a uterus; and ANNOVERA, a ring-shaped contraceptive vaginal system. The comp...
Show more
TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States and internationally. Its products portfolio includes IMVEXXY for the treatment of moderate-to-severe dyspareunia, a symptom of vulvar and vaginal atrophy due to menopause; BIJUVA to treat moderate-to-severe vasomotor symptoms due to menopause in women with a uterus; and ANNOVERA, a ring-shaped contraceptive vaginal system. The company also offers prescription prenatal vitamin products under the BocaGreenMD and vitaMedMD brand names. It has a license agreement with Mayne Pharma Group Limited. The company sells its products through wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- Phone
- 561 961 1900
- Website
- https://www.therapeuticsmd.com
- Address
- 951 Yamato Road, Suite 220, Boca Raton, United States
Latest news
No headlines yet.
